-
A key immune signal has a previously unknown role in turning off the immune system’s attack on pancreatic cancer cells, a new study finds. Led by researchers at NYU Grossman […]
Jan 08,2020
-
Immunotherapy is touted as the pancreatic cancer treatment option of the future. It involves using a personβs own immune system to fight and destroy cancer cells and is considered by […]
Nov 10,2019
-
An internationally renowned pancreatic surgeon, surgical oncologist, and cancer researcher, Christopher Wolfgang, MD, PhD, joined NYU Langone Health last January. He is chief of the new Division of Hepatobiliary and […]
Oct 01,2021
-
CAR T cells modified to recognise CEACAM7 were able to eliminate pancreatic ductal adenocarcinoma cells in a late-stage model without toxic effects on healthy tissue. Researchers have identified and validated […]
Jan 25,2021
-
Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium (DKTK), the Technical University of Munich (TUM), and […]
Jul 19,2021
-
A new study from Queen Mary University of London has demonstrated that immune cells can be stimulated to assemble into special structures within pancreatic cancer such that, at least in […]
Jul 09,2021
-
Researchers from Queen Mary University of London have identified a protein that could be used to aid in the diagnosis of pancreatic cancer. Findings from the new study suggest that […]
Jun 29,2021
-
Paris, France and New York, NY June 10, 2021 – AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France […]
Jun 10,2021